Clinical Trial

Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease

Name: Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease — clinical trial record (NCT07533890)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MicroSig

Recruiting

View on ClinicalTrials.gov →

Summary

In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-01

Trial Details

NCT Number	NCT07533890
Lead Sponsor	Insel Gruppe AG, University Hospital Bern Collaborators: Clinical Trials Unit University of Bern, University of Bern
Conditions	Inflamatory Bowel Disease
Enrollment	40 participants
Start Date	2026-05-01
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-30